French Beauty-Tech Startup Jolimoi Enters Liquidation Despite €10.5 Million in Funding and €20 Million Revenue

French beauty‑tech startup Jolimoi, founded in 2017 to bring social selling to the cosmetics market, raised a total of €10.5 million (including a €7 million Series A led by Seventure Partners) and reported €20 million in revenue in 2024. Despite reaching profitability in 2025, the company was placed into judicial liquidation in November 2026, ending operations and leaving its network of 10,000 stylists unpaid for pending commissions.

French Nuclear Startup Calogena Secures €40 Million EU Grant for District Heating Project

Calogena, a French clean‑tech startup, announced that it will receive €40 million of EU support to build a small nuclear reactor that can supply heat to city heating networks, starting with a pilot project in Pierrelatte. The funding will be used to design, license and install the technology, with the price of heat depending on the volume sold.

Swiss Biotech Startup Vale Biolabs Secures €164k Grant to Advance AI-Driven Brain Disease Research Platform

Swiss biotech startup Vale Biolabs secured a €164k grant from the Swiss accelerator Venture Kick to accelerate its AI‑driven human brain organoid platform, aiming to improve pre‑clinical testing for neurological diseases and reduce reliance on animal models.

Station F Reports Record €2 Billion in Startup Funding as Paris Campus Releases 2026 Future 40 List

Station F, the world’s largest startup campus in Paris, released its annual Future 40 ranking for 2026 and reported that its resident startups collectively raised a record €2 billion that year, underscoring the strength of its ecosystem across AI, deep‑tech, climate and health sectors.

Norwegian Biotech Vitroscope Raises $7 Million to Scale Perfusion Platform for Drug Discovery

Swiss biotech Vitroscope secured $7 million (a $5 million seed round co‑led by Cerberus Ventures and YZR Capital and $2 million of non‑dilutive funding from the Research Council of Norway) to bring its automated perfusion platform for living human tissue to more labs and develop a higher‑throughput version. The funding brings the company’s total capital raised to $8.8 million.